Log in to save to my catalogue

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sc...

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2549205204

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis

About this item

Full title

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2021-12, Vol.80 (12), p.1584-1593

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

ObjectivesClinical heterogeneity is a cardinal feature of systemic sclerosis (SSc). Hallmark SSc autoantibodies are central to diagnosis and associate with distinct patterns of skin-based and organ-based complications. Understanding molecular differences between patients will benefit clinical practice and research and give insight into pathogenesis...

Alternative Titles

Full title

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2549205204

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2549205204

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2021-220402

How to access this item